Late afternoon dosing of plerixafor for stem cell mobilization: A practical solution

Clinical Lymphoma, Myeloma and Leukemia

Volumn 11, Issue 3, 2011, Pages 267-272

  Cooper, Dennis L ^a   Pratt, Kathryn ^b   Baker, Julie ^a   Medoff, Erin ^a   Conkling Walsh, Ann ^b   Foss, Francine ^a   Snyder, Edward ^b   Yen, Wu ^b   Seropian, Stuart E ^a  

^a YALE CANCER CENTER   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

Autologous transplant; Lenalidomide; Plerixafor; Stem cell mobilization

Indexed keywords

BENDAMUSTINE; CD34 ANTIGEN; CISPLATIN; CYTARABINE; DEXAMETHASONE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; IMMUNOGLOBULIN; LENALIDOMIDE; PLERIXAFOR; HETEROCYCLIC COMPOUND;

ADULT; AGED; APHERESIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE PAIN; CELL COUNT; CLINICAL ARTICLE; DRUG DOSE ESCALATION; DRUG MEGADOSE; DRUG TREATMENT FAILURE; EVENING DOSAGE; FEMALE; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; MALE; MORNING DOSAGE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; NEUTROPENIA; NONHODGKIN LYMPHOMA; RETROSPECTIVE STUDY; SEPSIS; SIDE EFFECT; STEM CELL MOBILIZATION; THROMBOCYTE COUNT; LYMPHOMA; METABOLISM; MIDDLE AGED; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTIGENS, CD34; CELL COUNT; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HETEROCYCLIC COMPOUNDS; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80052020555     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2011.03.014     Document Type: Article

References (14)

1. W. Bensinger, F. Appelbaum, and S. Rowley Factors that influence collection and engraftment of autologous peripheral-blood stem cells J Clin Oncol 13 1995 2547 2555
2. C.H. Moskowitz, J.R. Glassman, and D. Wuest Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma Clin Cancer Res 4 1998 311 316 (Pubitemid 28122743)
3. D. Dingli, G.S. Nowakowski, and A. Dispenzieri Cyclophosphamide mobilization does not improve outcome in patients receiving stem cell transplantation for multiple myeloma Clin Lymphoma Myeloma 6 2006 384 388
4. I. Pusic, S.Y. Jiang, and S. Landua Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation Biol Blood Marrow Transplant 14 2008 1045 1056
5. S. Kumar, A. Dispenzieri, and M.Q. Lacy Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma Leukemia 21 2007 2035 2042 (Pubitemid 47299979)
6. J.F. DiPersio, I.N. Micallef, and P.J. Stiff Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma J Clin Oncol 27 2009 4767 4773
7. J.F. DiPersio, E.A. Stadtmauer, and A. Nademanee Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma Blood 113 2009 5720 5726
8. W.C. Liles, E. Rodger, and H.E. Broxmeyer Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist Transfusion 45 2005 295 300 (Pubitemid 40389423)
9. M.A. Gertz, S.M. Ansell, and D. Dingli Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative Mayo Clin Proc 83 2008 1131 1138
10. D.A. Stewart, C. Smith, and R. MacFarland Pharmacokinetics and pharmacodynamics of plerixafor in patients with non-Hodgkin lymphoma and multiple myeloma Biol Blood Marrow Transplant 15 2009 39 46
11. A. Cashen, S. Lopez, and F. Gao A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma Biol Blood Marrow Transplant 14 2008 1253 1261
12. H.-Y. Choi, C.-S. Yong, and B.K. Yoo Plerixafor for stem cell mobilization in patients with non-Hodgkin's lymphoma and multiple myeloma Ann Pharmacother 44 2010 117 126
13. L.L. Rosenbeck, S. Srivastava, and P.J. Kiel Peripheral blood stem cell mobilization tactics Ann Pharmacother 44 2010 107 116
14. M.A. Gertz, S.K. Kumar, and M.Q. Lacy Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma Bone Marrow Transplant 43 2009 619 625